News

Sera Prognostics, Inc. (SERA) Q2 2025 Earnings Call Transcript
Sera Prognostics, Inc. ( NASDAQ: SERA) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Austin Aerts - Chief Financial Officer Evguenia Lindgardt - President, CEO & Director Margarate ...
Cytek narrows 2025 revenue outlook to $196M-$205M amid recurring revenue growth and new product launches
Discover insights from Cytek Biosciences' Q2 2025 earnings call. Learn about revenue trends, recurring growth, new product launches, and future outlook.
Open Lending targets 22,500–24,500 certified loans for Q3 2025 while extending AmTrust partnership through 2033
Discover Open Lending's Q2 2025 insights: strategic priorities, AmTrust extension, financial highlights, and cautious optimism for growth in 2026.
Pursuit raises full-year EBITDA guidance by $10M as company accelerates acquisition strategy
Gain insights from Pursuit (PRSU)'s Q2 2025 earnings call: double-digit growth, raised guidance, Costa Rica acquisition, and $50M share buyback plan.
NextNav outlines FCC license acquisition and technical milestones while advancing 5G-based PNT strategy
Gain valuable insights from NextNav's Q2 2025 earnings call, including FCC milestones, financial updates, and strategic advancements in building ...
European markets stay in green, BOE interest rate decision in focus
The pan-European Stoxx 600 ( STOXX) gained 0.08% to 541.5 on Thursday, marking its fourth consecutive session of gains, while ...
Toyota anticipates $9.5 billion impact from tariffs, cuts profit outlook
Toyota Motor (TM) on Thursday said it expects a $9.5 billion hit from U.S. levies that have rattled the global automotive industry.
Davide Campari: Brand Strength And Recovery Ahead, Buy Confirmed
Davide Campari reported solid performance despite a challenging sector backdrop. Read more to find out why we remain buyers ...
Diageo: More Than The Economy Behind Revenue Weakness
Diageo faces weak FY2025 growth amid declining alcohol demand, despite emerging market strength and margin efforts. Read why ...
Corpay outlines 12% full-year revenue growth and $21.06 cash EPS guidance amid accelerated corporate payments momentum
Discover Corpay's Q2 2025 earnings performance—13% revenue growth, strategic M&A updates, and a focus on Corporate Payments.
Acadia raises 2025 NUPLAZID guidance to $665M–$690M as DAYBUE accelerates community uptake
Explore ACADIA Pharmaceuticals' Q2 2025 earnings highlights, featuring strong revenue growth, DAYBUE expansion, NUPLAZID guidance raise, and robust ...